Portage Biotech Stock Target Price and Analyst Consensus
PRTG Stock | USD 4.03 0.08 1.95% |
The current analyst and expert consensus on Portage Biotech is Hold, with no strong buy opinions. The current projected Portage Biotech target price consensus is 10.00 with 1 analyst opinions. Check out Macroaxis Advice on Portage Biotech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.The most common way Portage Biotech analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Portage Biotech executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Portage Biotech. We encourage you to use your own analysis of Portage Biotech to validate this buy or sell advice. Portage Biotech buy-or-sell recommendation module provides average expert sentiment on the projected Portage Biotech target price to derive its highest and lowest estimates based on projected price volatility of 17.0043.
Lowest Forecast 9.1 | Highest Forecast 11.1 | Target Price 10 |
Portage |
It's important to approach Portage Biotech's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Portage Biotech Target Price Consensus
Portage target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Portage Biotech's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
One | Hold |
Most Portage analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Portage stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Portage Biotech, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationPortage Biotech Target Price Projection
Portage Biotech's current and average target prices are 4.03 and 10.00, respectively. The current price of Portage Biotech is the price at which Portage Biotech is currently trading. On the other hand, Portage Biotech's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Portage Biotech Market Quote on 6th of December 2024
Target Price
Analyst Consensus On Portage Biotech Target Price
Portage Biotech Analyst Ratings
Portage Biotech's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Portage Biotech stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Portage Biotech's financials, market performance, and future outlook by experienced professionals. Portage Biotech's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Portage Biotech price targets
Portage Biotech's stock target price is an estimate of its future price, usually made by analysts. Using Portage Biotech's target price to determine if it is a suitable investment can be done through the following steps:- Look at Portage Biotech's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Portage Biotech's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Portage Biotech Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Portage Biotech is a key component of Portage Biotech valuation and have some predictive power on the future returns of a Portage Biotech.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Portage Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.Macroaxis Index Invested few shares | ||
Baby Boomer Prospects Invested one share | ||
Personal Services Invested over 90 shares | ||
Beers Invested over 90 shares |
Check out Macroaxis Advice on Portage Biotech to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.